Recent Finacing
Recent Raise
Rose Diagnostics develops lymph biomarkers and a point-of-care lung cancer biopsy-sample screening test combining a multiplexed dynamic predictive algorithm with sandwiched immunoassay and lateral-flow formats, pursuing validation and FDA approval.